|
|
|
|
Vol. 300, Issue 2, 408-416, February 2002
Blânchette Rockefeller Neurosciences Institute, Rockville,
Maryland; and Laboratory of Adaptive Systems, National Institute of
Neurological Disorders and Stroke/National Institutes of Health,
Bethesda, Maryland
Hypoxia significantly reduced cholinergic
activity in rat CA1 field
and intracellular
in the CA1 pyramidal cells, recorded in
hippocampal slices. The hypoxic responses of the hippocampal CA1
pyramidal cells to a brief hypoxia consisted of a short period of
"synaptic arrest", observed as an elimination of excitatory postsynaptic current under voltage clamp and recovered immediately as
oxygenation was reinitiated. The hypoxic synaptic arrest was not
associated with reduced postsynaptic responses of the pyramidal cells
to externally applied L-glutamate, suggesting that the
synaptic arrest might result from a presynaptic mechanism. The hypoxic synaptic arrest was abolished in the presence of
8-cyclopentyl-1,3-dipropylxanthine (DPCPX), a specific adenosine
A1 receptor antagonist. Blocking adenosine A1
receptors also eliminated effects of hypoxia on the hippocampal CA1
field
activity and intracellular
of the CA1 pyramidal cells. In
behaving rats, brief hypoxia impaired their water maze performance in
both the escape latency and probe tests. The impairment was prevented
by intralateral cerebroventricular injections of DPCPX. These results
suggest that hypoxia releases adenosine and produces an inhibition of
synaptic transmission and intracellular signal cascade(s) involved in
generation/maintenance of hippocampal CA1
activity. This protection
of synaptic efficacy and spatial learning through adenosine
A1 receptor antagonism may represent an effective
therapeutic strategy to eliminate functional interruption due to
transient hypoxic episodes and/or chronic hypoxia secondary to
compromise of respiratory function.
This article has been cited by other articles:
![]() |
A. Bekker, M. Haile, K. Gingrich, L. Wenning, A. Gorny, D. Quartermain, and T. Blanck Physostigmine Reverses Cognitive Dysfunction Caused by Moderate Hypoxia in Adult Mice Anesth. Analg., September 1, 2007; 105(3): 739 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Bruggemans, A. van Boxtel, and H. A. Huysmans INVITED COMMENTARY Ann. Thorac. Surg., April 1, 2005; 79(4): 1314 - 1315. [Full Text] [PDF] |
||||